Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Renal Cell 58Sarcoma 39Neoplasm Metastasis 22Neoplasms 20Ovarian Neoplasms 17Breast Neoplasms 17Carcinoma, Non-Small-Cell Lung 15Recurrence 7Leiomyosarcoma 7Kidney Neoplasms 7Melanoma 6Liposarcoma 6Hemangiosarcoma 6Glioblastoma 6Fallopian Tube Neoplasms 6Thyroid Neoplasms 5Prostatic Neoplasms 5Neurofibrosarcoma 5Lung Neoplasms 5Urinary Bladder Neoplasms 4Sarcoma, Synovial 4Pancreatic Neoplasms 4Osteosarcoma 4Histiocytoma, Malignant Fibrous 4Dermatofibrosarcoma 4Clear-cell metastatic renal cell carcinoma 4Chondrosarcoma, Extraskeletal Myxoid 4Uterine Cervical Neoplasms 3Solid Tumors 3Small Cell Lung Carcinoma 3

Interventions

Paclitaxel 2Carboplatin 2selinexor 1pazopanib 1Watchful Waiting 1Transurethral Resection of Prostate 1Pregnancy Tests 1Naproxen 1Human Papillomavirus DNA Tests 1GX-188 vaccine 1Filgrastim 1Educational Status 1Drug Therapy 1Colposcopy 1Biopsy 1Anesthesia, General 1Acetic Acid 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uterine Diseases × pazopanib × Clear all
NCT00561795 2012-03-22

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

GlaxoSmithKline

Phase 2 Completed
12 enrolled 6 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Diseases, Neoplasms, Ovarian Neoplasms, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡